RCMI Coordinating Center (RCMI CC) Header Logo

Connection

David Mootoo to HIV-1

Back to Details
This is a "connection" page, showing publications David Mootoo has written about HIV-1.
David Mootoo
Connection Strength
0.096
HIV-1
  1. Garg H, Francella N, Tony KA, Augustine LA, Barchi JJ, Fantini J, Puri A, Mootoo DR, Blumenthal R. Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry. Antiviral Res. 2008 Oct; 80(1):54-61.
    View in: PubMed
    Score: 0.052
  2. Augustin LA, Fantini J, Mootoo DR. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120. Bioorg Med Chem. 2006 Feb 15; 14(4):1182-8.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support